OPINIONImmunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMIBy Michael BrownJan 22, 2018 7:23 PM EST
PRESS RELEASESCellectis And Servier Expand Collaboration On UCART19 ProductsBy Business WireFeb 18, 2020 4:30 PM EST
PRESS RELEASESFirst Patient Dosed With Cellectis' New Allogeneic UCART123 Product Candidate For Relapsed/Refractory Acute Myeloid LeukemiaBy Business WireJan 15, 2020 4:30 PM EST
OPINIONImmunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMIBy Michael BrownJan 22, 2018 7:23 PM EST
STOCKSImmunotherapy stocks power higher on Celgene-Juno dealBy Armie Margaret LeeJan 22, 2018 12:03 PM EST
HEALTHGene Editing Company Joins NASDAQ, Jumps Over 20% on First DayBy Melissa AngellJul 21, 2017 12:26 PM EDT
STOCKSTired of hearing about Blue Apron's fall? Check out the next wave of talked about IPOsBy Michael BrownJul 17, 2017 12:12 PM EDT
HEALTHMove Over GMO's: IPO for Gene Editor Calyxt Launches Next WeekBy Melissa AngellJul 10, 2017 5:09 PM EDT
STOCKSCellectis gains FDA nod to test new gene-edited cancer treatmentBy Gregg GreenbergFeb 7, 2017 12:27 PM EST
VIDEOCellectis Gets FDA Nod to Test New Gene-Edited Cancer TreatmentBy Gregg GreenbergFeb 7, 2017 12:14 PM EST
OPINION13 companies to watch from MIT's smart 50 list, including 4 buysBy Robert WassermanJul 21, 2016 7:48 AM EDT
MARKETSTrade-Ideas: Cellectis (CLLS) Is Today's Weak On High Relative Volume StockBy TheStreet WireJul 8, 2016 10:33 AM EDT
STOCKSJuno, Kite valuations at risk from simpler T-Cell cancer therapyBy Adam FeuersteinJan 26, 2016 11:15 AM EST
STOCKSJuno, Kite, Novartis Yelp 'Oh Merde!' at Cellectis Off-the-Shelf CAR-T DataBy Adam FeuersteinNov 5, 2015 11:21 AM EST
INVESTINGSpark Therapeutics Trial Success Seen As Positive For Gene Therapy SectorBy The Fly StaffOct 5, 2015 10:53 AM EDT
INVESTINGBiotech Selloff Has No Effect on Cellectis Advances: CEOBy Gregg GreenbergAug 26, 2015 11:29 AM EDT
VIDEOBiotech Selloff Does Not Dim Immunotherapy Advances Says Cellectis CEOBy Gregg GreenbergAug 26, 2015 11:05 AM EDT
MARKETSPfizer (PFE) Stock Gaining on Rare Lung Disorder Treatment ApprovalBy Tony OwusuMay 29, 2015 2:59 PM EDT
JIM CRAMER'Mad Money' Lightning Round: Do Not Sell Boeing StockBy Scott RuttMay 29, 2015 11:36 AM EDT
